NDC 13533-690

Plasbumin

Albumin (human)

Plasbumin is a Intravenous Solution in the Plasma Derivative category. It is labeled and distributed by Grifols Usa, Llc. The primary component is Albumin Human.

Product ID13533-690_21a20866-f2c2-4b6d-9a3f-acd2cc1b9f4a
NDC13533-690
Product TypePlasma Derivative
Proprietary NamePlasbumin
Generic NameAlbumin (human)
Dosage FormSolution
Route of AdministrationINTRAVENOUS
Marketing Start Date1994-09-26
Marketing CategoryBLA / BLA
Application NumberBLA101138
Labeler NameGRIFOLS USA, LLC
Substance NameALBUMIN HUMAN
Active Ingredient Strength3 g/50mL
Pharm ClassesHuman Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 13533-690-20

1 VIAL in 1 CARTON (13533-690-20) > 50 mL in 1 VIAL (13533-690-21)
Marketing Start Date1994-09-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 13533-690-28 [13533069028]

Plasbumin SOLUTION
Marketing CategoryBLA
Application NumberBLA101138
Product TypePLASMA DERIVATIVE
Marketing Start Date2012-12-05

NDC 13533-690-20 [13533069020]

Plasbumin SOLUTION
Marketing CategoryBLA
Application NumberBLA101138
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date1994-09-26

NDC 13533-690-27 [13533069027]

Plasbumin SOLUTION
Marketing CategoryBLA
Application NumberBLA101138
Product TypePLASMA DERIVATIVE
Marketing Start Date1994-09-26

NDC 13533-690-25 [13533069025]

Plasbumin SOLUTION
Marketing CategoryBLA
Application NumberBLA101138
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date1994-09-26

NDC 13533-690-21 [13533069021]

Plasbumin SOLUTION
Marketing CategoryBLA
Application NumberBLA101138
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2012-12-05

NDC 13533-690-26 [13533069026]

Plasbumin SOLUTION
Marketing CategoryBLA
Application NumberBLA101138
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2012-12-05

Drug Details

Active Ingredients

IngredientStrength
ALBUMIN HUMAN2.5 g/50mL

Pharmacological Class

  • Human Serum Albumin [EPC]
  • Increased Intravascular Volume [PE]
  • Increased Oncotic Pressure [PE]
  • Osmotic Activity [MoA]
  • Serum Albumin [Chemical/Ingredient]

NDC Crossover Matching brand name "Plasbumin" or generic name "Albumin (human)"

NDCBrand NameGeneric Name
13533-683PlasbuminAlbumin (Human)
13533-684PlasbuminAlbumin (Human)
13533-690PlasbuminAlbumin (Human)
13533-691PlasbuminAlbumin (Human)
13533-692PlasbuminAlbumin (Human)
0053-7680Albuminar-25Albumin (Human)
0053-7670Albuminar-5Albumin (Human)
44206-251AlbuRxALBUMIN (HUMAN)
44206-310ALBURXALBUMIN (HUMAN)
68516-5214ALBUTEINALBUMIN (HUMAN)
68516-5215ALBUTEINALBUMIN (HUMAN)
68516-5216ALBUTEINALBUMIN (HUMAN)
61953-0001HUMAN ALBUMIN GRIFOLSALBUMIN (HUMAN)
61953-0002HUMAN ALBUMIN GRIFOLSALBUMIN (HUMAN)

Trademark Results [Plasbumin]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PLASBUMIN
PLASBUMIN
73197739 1136564 Live/Registered
CUTTER LABORATORIES, INC.
1978-12-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.